LONG-TERM RESULTS OF THROMBOCYTAPHERESIS INCLUDED IN COMBINED TREATMENT OF BRONCHIAL-ASTHMA

A long-term follow-up (within 18 months) has been conducted of bronchi al asthma (BA) patients (a total of 29 cases with atopic, aspirin and mixed BA forms) subjected to thrombocytapheresis. The examination perf ormed in 12 month intervals included a berotec test, assessment of pla telet aggregation, platelet intracellular calcium metabolism, external respiration function (ERF). The treatment resulted in remission of 4- 18 month duration. It was characterized by ERF normalization, high sen sitivity to sympathomimetics, platelet status improvement. The best re sults were achieved in the groups of atopic and aspirin asthma patient s. The findings allow recommendation of thrombocytapheresis as a metho d of choice in combined therapy of BA.